The Effects of Covid-19 on Development of Deep Venous Thrombosis: Bibliographic Review
Keywords:
covid-19; sars-cov-2; deep vein thrombosis; coagulation
Abstract
The new coronavirus 2019 (COVID-19) is clinically characterized by the multisystemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose symptoms and prognosis depend on the stage of the disease in which the patient is. In aggravating cases, it is necessary to use mechanical ventilation or treatment in intensive care units (ICU), taking into account the high risk of mortality. Although the fundamental clinical features of the disease are respiratory, neurological, renal, digestive, cardiac and other organ complications also exist. The work in question, given the volume of clinical trials, seeks to effectively investigate potential therapies for COVID-19, highlighting the need to produce high-quality evidence. In addition, the biological plausibility of the thrombotic risk in SARS-CoV-2 and its cardiac involvement due to the exacerbated inflammatory response and due to pre-existing manifestations or due to acquired manifestations was discussed.
Downloads
How to Cite
References
Referências Bibliográficas (null) REFERÊNCIAS BIBLIOGRÁFICAS.
Arno Bourgonje, Amaal Abdulle, Wim Timens, Jan‐luuk Hillebrands, Gerjan Navis, Sanne Gordijn, Marieke Bolling, Gerard Dijkstra, Adriaan Voors, Albert Osterhaus, Peter Van Der Voort, Douwe Mulder, Harry Van Goor (2020) Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). 251(3), 228-248.
Simone Brandão, Emmanuelle Godoi, Júlia Ramos, Leila Melo, Emanuel Sarinho (2020) COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica. 19.
Raquel Faria, Graziela Carvalheiras, Rute Alves, Daniel G. Oliveira, Mariana Brandão, Pedro Vita, António Marinho (2021) Janela de Oportunidade para a Imunomodulação na COVID-19. 19, 35-41.
S (2020) Unknown Title. 27.
J; Guerra, F; Carbonieri, R Fittipaldi (2020) EVIDÊNCIAS CIENTÍFICAS ACERCA DA COVID-19. Anticoagulação na Prática. 1-52.
Tomasz Guzik, Saidi Mohiddin, Anthony Dimarco, Vimal Patel, Kostas Savvatis, Federica Marelli-Berg, Meena Madhur, Maciej Tomaszewski, Pasquale Maffia, Fulvio D'acquisto, Stuart Nicklin, Ali Marian, Ryszard Nosalski, Eleanor Murray, Bartlomiej Guzik, Colin Berry, Rhian Touyz, Reinhold Kreutz, Dao Wang, David Bhella, Orlando Sagliocco, Filippo Crea, Emma Thomson, Iain Mcinnes (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. 116(10), 1666-1687.
Markus Hoffmann (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. 1-20.
Nickolas Kipshidze, George Dangas, Christopher White, Nodar Kipshidze, Fakiha Siddiqui, Christopher Lattimer, Charles Carter, Jawed Fareed (2020) Viral Coagulopathy in Patients With COVID-19: Treatment and Care. 26.
Mariusz Kowalewski, Dario Fina, Artur Słomka, Giuseppe Raffa, Gennaro Martucci, Valeria Lo Coco, Maria De Piero, Marco Ranucci, Piotr Suwalski, Roberto Lorusso (2020) COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review. 24(1), 205.
Ministério Da Saúde (2020) Lidando com os riscos de segurança digital durante a crise da COVID-19. 19.
S (2020) https://konferencefzsplzen.files.wordpress.com/2020/11/sbornik-2020.pdf. 1-49.
A Rente, D Junior, K Uezato, Coronavírus E O Coração (2020) Um Relato deCaso sobre a Evolução da COVID-19 Associado à Evolução Cardiológica. 1-4.
Piercarlo Sarzi-Puttini, Valeria Giorgi, Silvia Sirotti, Daniela Marotto, Sandro Ardizzone, Giuliano Rizzardini, Spinello Antinori, Massimo Galli (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?. 38(2), 337-342.
S Srivastava (2020) COVID-19 infection and thrombosis. 510, 344-346.
Maria Yee, Adeolu Oladunjoye, Larry Rotenberg (2020) Deep Venous Thrombosis in a 62-Year-Old Female With Schizoaffective Disorder Who Developed COVID-19. 46.
Published
2022-07-15
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.